Global Onychomycosis (Tinea Unguium) Drug Competitive Landscape Professional Research Report 2025
Description
Global Onychomycosis (Tinea Unguium) Drug Competitive Landscape Professional Research Report 2025
Research Summary
Onychomycosis, also known as tinea unguium, refers to a fungal infection of the nails, most commonly affecting the toenails but can also affect the fingernails. Onychomycosis drugs, or antifungal medications, are used to treat and manage this condition. These drugs can be administered orally, topically, or through a combination of both, depending on the severity of the infection. They work by inhibiting the growth of the fungi responsible for the nail infection, ultimately leading to the elimination of the fungal presence and the restoration of healthy nail growth. Onychomycosis drugs play a crucial role in addressing a common and often persistent condition that can impact the appearance and health of the nails, and they are typically prescribed and monitored by healthcare professionals.
According to DIResearch's in-depth investigation and research, the global Onychomycosis (Tinea Unguium) Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Onychomycosis (Tinea Unguium) Drug include Bausch Health, Kaken Pharmaceutical, Galderma, Johnson & Johnson, Sato Pharmaceutical , Karo Healthcare, Pfizer, Qilu Pharmaceutical, Jiangsu Fubang Pharmaceutical, Chengdu Brilliant Pharmaceutical, Harbin Medisan Pharmaceutical, Letai Pharmaceutical, Shandong Buchang Pharmaceuticals, Hubei Heng＇an Fulin Pharmaceutical, Honz Pharmaceutical, Tianjin Lisheng Pharmaceutical, Nanjing Cuccess Pharmaceutical, Shanghai Huanhua Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Onychomycosis (Tinea Unguium) Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Onychomycosis (Tinea Unguium) Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Onychomycosis (Tinea Unguium) Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Onychomycosis (Tinea Unguium) Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Onychomycosis (Tinea Unguium) Drug Include:
Bausch Health
Kaken Pharmaceutical
Galderma
Johnson & Johnson
Sato Pharmaceutical
Karo Healthcare
Pfizer
Qilu Pharmaceutical
Jiangsu Fubang Pharmaceutical
Chengdu Brilliant Pharmaceutical
Harbin Medisan Pharmaceutical
Letai Pharmaceutical
Shandong Buchang Pharmaceuticals
Hubei Heng＇an Fulin Pharmaceutical
Honz Pharmaceutical
Tianjin Lisheng Pharmaceutical
Nanjing Cuccess Pharmaceutical
Shanghai Huanhua Pharmaceutical
Onychomycosis (Tinea Unguium) Drug Product Segment Include:
Oral Drug
Topical Drug
Onychomycosis (Tinea Unguium) Drug Product Application Include:
Age under 18
Age 18-50
Age above 50
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Onychomycosis (Tinea Unguium) Drug Industry PESTEL Analysis
Chapter 3: Global Onychomycosis (Tinea Unguium) Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Onychomycosis (Tinea Unguium) Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Onychomycosis (Tinea Unguium) Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Onychomycosis (Tinea Unguium) Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Onychomycosis (Tinea Unguium) Drug Product by Type
- 1.2.1 Oral Drug
- 1.2.2 Topical Drug
- 1.3 Onychomycosis (Tinea Unguium) Drug Product by Application
- 1.3.1 Age under 18
- 1.3.2 Age 18-50
- 1.3.3 Age above 50
- 1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size Analysis (2020-2032)
- 1.5 Onychomycosis (Tinea Unguium) Drug Market Development Status and Trends
- 1.5.1 Onychomycosis (Tinea Unguium) Drug Industry Development Status Analysis
- 1.5.2 Onychomycosis (Tinea Unguium) Drug Industry Development Trends Analysis
- 2 Onychomycosis (Tinea Unguium) Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Regions
- 4.1 Onychomycosis (Tinea Unguium) Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2026-2032)
- 5 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type and Application
- 5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2020-2032)
- 5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 6.5 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 7.5 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 8.4 China Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 9.4 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 9.5 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 10.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 10.5 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 11.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 11.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Onychomycosis (Tinea Unguium) Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bausch Health
- 13.1.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bausch Health Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.1.3 Bausch Health Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Kaken Pharmaceutical
- 13.2.1 Kaken Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.2.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Galderma
- 13.3.1 Galderma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Galderma Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.3.3 Galderma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.4.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Sato Pharmaceutical
- 13.5.1 Sato Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Sato Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.5.3 Sato Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Karo Healthcare
- 13.6.1 Karo Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Karo Healthcare Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.6.3 Karo Healthcare Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Pfizer
- 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.7.3 Pfizer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Qilu Pharmaceutical
- 13.8.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.8.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Jiangsu Fubang Pharmaceutical
- 13.9.1 Jiangsu Fubang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Jiangsu Fubang Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.9.3 Jiangsu Fubang Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Chengdu Brilliant Pharmaceutical
- 13.10.1 Chengdu Brilliant Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Chengdu Brilliant Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.10.3 Chengdu Brilliant Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Harbin Medisan Pharmaceutical
- 13.11.1 Harbin Medisan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Harbin Medisan Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.11.3 Harbin Medisan Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Letai Pharmaceutical
- 13.12.1 Letai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Letai Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.12.3 Letai Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Shandong Buchang Pharmaceuticals
- 13.13.1 Shandong Buchang Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Shandong Buchang Pharmaceuticals Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.13.3 Shandong Buchang Pharmaceuticals Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Hubei Heng＇an Fulin Pharmaceutical
- 13.14.1 Hubei Heng＇an Fulin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Hubei Heng＇an Fulin Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.14.3 Hubei Heng＇an Fulin Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Honz Pharmaceutical
- 13.15.1 Honz Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Honz Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.15.3 Honz Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Tianjin Lisheng Pharmaceutical
- 13.16.1 Tianjin Lisheng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Tianjin Lisheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.16.3 Tianjin Lisheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Nanjing Cuccess Pharmaceutical
- 13.17.1 Nanjing Cuccess Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Nanjing Cuccess Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.17.3 Nanjing Cuccess Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 Shanghai Huanhua Pharmaceutical
- 13.18.1 Shanghai Huanhua Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Shanghai Huanhua Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.18.3 Shanghai Huanhua Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
- 14.2 Onychomycosis (Tinea Unguium) Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Onychomycosis (Tinea Unguium) Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Onychomycosis (Tinea Unguium) Drug Typical Downstream Customers
- 14.4 Onychomycosis (Tinea Unguium) Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
